Skip to main content
LESL logo

LESL · Leslie's, Inc.

Track LESL — free
$0.10 -0.05 (-32.94%)
Market Cap
$2.74M
Shares
9.37M
Volume · Oct 5 10.64M Avg daily vol (3M) 4.28M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.15 Open$0.17 Day$0.14–0.17 52W close$0.15–10.76 Avg vol 30d7.0M Short int1.8M · 18.8% float · 6.7d Short vol53% Last earningsAug 12, 2026 DataOct 2020–Oct 2026 Filing10-Q · Aug 12

Up next

Next earnings call
Nov 8, 2026 Est · unconfirmed · in 5 wks
filed Aug 12, 2026
call held May 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.18B
Trailing 12 months
Net income (TTM)
−$250.49M
Trailing 12 months
Revenue growth YoY
-8.4%
Year over year
Operating margin
-16.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-231.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.9%
Year over year · more shares
Price change (1Y)
-97.4%
Trailing year
Short interest
18.8%
Latest settlement · 6.7 days to cover
View all 115 metrics

AI Brief

Q3 FY26 earnings call · Aug 12, 2026
Q3 FY26

TL;DR. Leslie's posted an 8.4% Q3 sales decline and a 31.7% drop in adjusted EBITDA on softer consumer demand, and withdrew its previously issued full-year sales and adjusted EBITDA guidance without updating it, while continuing to explore a potential deleveraging transaction with financial stakeholders.

Bullish
  • + Q3 net income rose $26.1 million year-over-year to $47.8 million, helped by a $17.5 million credit card interchange settlement gain.
  • + SG&A improved 270 bps to 23.2% of sales on disciplined cost management and lower store operating costs.
  • + Inventory fell 15% to $233.4 million, reflecting progress on inventory optimization.
  • + Company has $207 million of total liquidity and is actively exploring strategic alternatives, including a deleveraging transaction, to strengthen the balance sheet.
Bearish
  • − Q3 sales fell 8.4% to $458.5 million with comparable sales down 6.2% on lower traffic and softer demand.
  • − Q3 adjusted EBITDA dropped to $55.7 million from $81.6 million on volume and gross margin pressure.
  • − Gross margin contracted to 36.5% from 39.6% on unfavorable mix and higher distribution costs.
  • − Company withdrew its previously issued full-year fiscal 2026 sales and adjusted EBITDA guidance and is not providing an updated outlook.
  • − Net long-term debt of $753 million and stockholders' deficit of $492.7 million underscore the balance sheet stress driving the strategic review.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −94%
below
Price vs 50-day avg −78%
below
RSI (14) 23
oversold
MACD trend Positive
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return −73%
trailing
6-month return −90%
trailing
YTD return −91%
this year
Relative strength −102%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+7% holders QoQ · +14 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
18.76% of float · ▼ -4.7% MoM · 6.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
47 holders — mid 3-yr range
Squeeze score 67
elevated · 0–100
Fundamentals
Weak
Revenue growth −7%
Y/Y
Gross margin 35%
contracting
EPS growth −911%
Y/Y
Free cash flow $-16.7M
Buyback $147.7M
remaining
Balance sheet $687.7M
net debt
Quant / Vol
risk profile
Very High
Volatility 219%
annualized · 1-yr
Max drawdown −99%
past year
ATR 74.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 3
Latest guidance · from the 8-K filed May 13, 2026
Sales · full year fiscal 2026 Initiated $1.1B – $1.25B
prior FY $1.24B midpoint −5.4% Y/Y
Guided vs delivered · last 3 settled
Sales full year of fiscal 2024
guided $1.32B – $1.35B
$1.33B In line
Sales full year of Fiscal 2023
guided $1.43B – $1.45B
$1.45B Beat +0.8%
Sales full year fiscal 2021
guided $1.25B – $1.27B
$1.34B Beat +6.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−94% Bearish
Price vs 50-day avg
−78% Bearish
RSI (14)
23 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+7% holders QoQ · +14 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
18.76% of float · ▼ -4.7% MoM · 6.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
47 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $11
vs 200-day avg -94% vs 50-day avg -78%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted diluted loss per share non-GAAP -$8.55 Fiscal Nine Months Ended July 4, 2026 —
Adjusted EBITDA non-GAAP -11.4M Fiscal Nine Months Ended July 4, 2026 —
Adjusted EBITDA as a percentage of sales non-GAAP 12.1% Three Months Ended July 4, 2026 filing —
Adjusted net loss non-GAAP -79.7M Fiscal Nine Months Ended July 4, 2026 —
Capital expenditures 10.5M period ended July 4, 2026 —
Comparable sales non-GAAP 5.5% Fiscal Nine Months Ended July 4, 2026 —
Comparable sales growth -6.2% Three Months Ended July 4, 2026 filing —
Number of locations open at end of period 943 Three Months Ended July 4, 2026 filing —
Number of new and acquired locations, net -1 Three Months Ended July 4, 2026 filing —
Total liquidity 207.1M as of July 4, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Retail — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LESL
Leslie's, Inc.
this stock
$2.74M -91.2% -6.6% — 18.8%
WSM
Williams Sonoma Inc
$27.31B +30.1% +1.2% 23.8 4.9%
ULTA
Ulta Beauty, Inc.
$23.31B -10.1% +9.7% 19.9 5.7%
CASY
Caseys General Stores Inc
$22.17B +11.8% +10.2% 28.9 4.1%
BBY
Best Buy Co Inc
$18.61B +31.4% +0.4% 14.8 7.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
47
% held
57.7%
Net QoQ
-109.2K sh
Top holder
ARIEL INVESTMENTS, LLC
Held Float
View
Held by Funds
Fund positions
28
View
Short & Settlement
Short Interest Falling
Shares short
1.8M
Days to cover
6.7d
Change
-87.2K sh
View
Short Volume
Short vol %
53%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
2.5K
Value
$1.3K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
61.3%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Susie Lee
Amount
$1.0K–$15.0K
Traded
Nov 30, 2022
View
Financials
Financials
Revenue (FY)
$1.2B
Net income (FY)
$-237.0M
EPS diluted
$-25.57
View
Buybacks
Authorized
$300.0M
Remaining
$147.7M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 30, 2026
This year
14
View
Earnings & Events
Webcasts
Last webcast
Aug 12, 2026
View

Performance

5D 20D 120D MTD YTD
LESL -50.2% -73.4% -89.5% -8.9% -91.2%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -49.9% -72.9% -101.7% -9.9% -104.0%

Capital returns

Buyback program · as of Dec 28, 2024
Authorized
$300.00M
Spent (derived)
$152.30M
Remaining
$147.70M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1821806 CUSIP 527064208 13F (30d) 1 filings 1 filers Visit website Investor relations